Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

1.96
Delayed Data
As of 10:17am ET
 +0.01 / +0.51%
Today’s Change
1.84
Today|||52-Week Range
8.95
-74.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$48.9M

Company Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage pharmaceutical company. It is engaged in developing and manufacturing new pharmaceutical products that are used in central nervous system drugs in large and growing markets. It products include TNX-102 SL and TNX-201. Tonix Pharmaceuticals Holding was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.

Contact Information

Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue
New York New York 10022
P:(212) 980-9155
Investor Relations:

Employees

Shareholders

Mutual fund holders6.73%
Individual stakeholders5.39%
Other institutional25.30%

Top Executives

Seth LedermanChairman, President & Chief Executive Officer
Bradley SaengerChief Financial Officer
Gregory M. SullivanChief Medical Officer
Bruce L. DaughertySecretary, Chief Scientific Officer & Controller
Jessica Edgar MorrisExecutive Vice President-Administration